Shu Zhao
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 7
- Cancer Cells and Metastasis 3
- Bone health and treatments 3
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 3
- Immunology top 10%
- Immune Cell Function and Interaction 4
-
- Lung Cancer Treatments and Mutations 6
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 13
-
- Metabolism, Diabetes, and Cancer 3
- Cited by
- OncologyCancer ResearchImmunology
- Partner nations
- ChinaUnited States
In The Last Decade
Shu Zhao
41 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 91
- Oncology 785
- Cancer Research 409
- Immunology 239
- Pulmonary and Respiratory Medicine 337
- Pathology and Forensic Medicine 134
Countries citing papers authored by Shu Zhao
This map shows the geographic impact of Shu Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Zhao more than expected).
Fields of papers citing papers by Shu Zhao
This network shows the impact of papers produced by Shu Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Zhao. The network helps show where Shu Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shu Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 6 | |
| 9 | 2020 | 32 | |
| 10 | 2019 | 13 | |
| 11 | 2019 | 6 | |
| 12 | 2015 | 60 | |
| 13 | 2015 | 50 | |
| 14 | 2015 | 24 | |
| 15 | 2013 | 48 | |
| 16 | 2012 | 41 | |
| 17 | 2011 | 55 | |
| 18 | 2011 | 14 | |
| 19 | 2008 | 53 | |
| 20 | Study on incidence and risk factors associated with postpartum depression | 2008 | 2 |
About Shu Zhao
Shu Zhao is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research, having authored 43 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (13 papers), Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (6 papers), Immune Cell Function and Interaction (4 papers), Cancer Cells and Metastasis (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Bone health and treatments (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Oncology (785 citations), Cancer Research (409 citations) and Immunology (239 citations). Shu Zhao has collaborated with scholars based in China and United States. Frequent co-authors include Minghui Zhang, Haihong Pu, Qingyuan Zhang, Yan Wang, Jingxuan Wang, Qingyuan Zhang, Wenjie Ma, Qijia Xuan, Yupeng Liu and Minghui Zhang. Their work appears in journals such as PLoS ONE, Scientific Reports and Environment International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.